These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17872334)

  • 1. [Genetic background of esophageal squamous cell carcinoma].
    Hagymási K; Tulassay Z
    Orv Hetil; 2007 Sep; 148(38):1795-800. PubMed ID: 17872334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protamine sulfate-nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells.
    Cao M; Deng X; Su S; Zhang F; Xiao X; Hu Q; Fu Y; Yang BB; Wu Y; Sheng W; Zeng Y
    Nanoscale; 2013 Dec; 5(24):12120-5. PubMed ID: 24154605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the pathogenesis and immunotherapy of esophageal squamous cell carcinoma.
    Cervantes J
    Rev Gastroenterol Peru; 2004; 24(2):165-70. PubMed ID: 15241495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis.
    Sakakura C; Miyagawa K; Fukuda KI; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ida H; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Ito K; Hagiwara A; Ito Y
    Oncogene; 2007 Aug; 26(40):5927-38. PubMed ID: 17384682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.
    Haruki S; Imoto I; Kozaki K; Matsui T; Kawachi H; Komatsu S; Muramatsu T; Shimada Y; Kawano T; Inazawa J
    Carcinogenesis; 2010 Jun; 31(6):1027-36. PubMed ID: 20200074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic aberrations and targeted epigenetic therapy of esophageal cancer.
    Zhao R; Casson AG
    Curr Cancer Drug Targets; 2008 Sep; 8(6):509-21. PubMed ID: 18781897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation status of retinoic acid receptor beta2 promoter and global DNA in esophageal squamous cell carcinoma.
    Li RN; Yu FJ; Wu CC; Chen YK; Yu CC; Chou SH; Lee JY; Cheng YJ; Wu MT; Wu IC
    J Surg Oncol; 2014 May; 109(6):623-7. PubMed ID: 24510455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data mining and bioinformatics of the expression data of esophageal squamous cell carcinoma.
    Sun Y; Li X; Jiang C; Xiao M; Zheng Y; Zhang J; Bu J
    Cell Biochem Biophys; 2014 Jul; 69(3):481-5. PubMed ID: 24595844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinnoma].
    Shiozaki H; Yano M
    Nihon Geka Gakkai Zasshi; 2002 Mar; 103(3):284-9. PubMed ID: 11968758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic events during development of esophageal squamous cell carcinoma].
    Sasaki H; Watanabe H; Terada M
    Nihon Rinsho; 1996 Apr; 54(4):1060-5. PubMed ID: 8920674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress of gene therapy for esophageal cancer in Japan].
    Matsubara H; Ochiai T
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):944-9. PubMed ID: 12894708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental gene therapy using p21/WAF1 gene in esophageal squamous cell carcinoma--adenovirus infection and gene gun technology].
    Fujii T; Tanaka Y; Tanaka T; Matono S; Sueyoshi S; Fujita H; Shirouzu K; Kato S; Yamana H
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1651-4. PubMed ID: 11708000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
    Kitagawa Y; Ueda M; Ando N; Shinozawa Y; Shimizu N; Abe O
    Cancer Res; 1991 Mar; 51(5):1504-8. PubMed ID: 1997190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental gene therapy using p21Waf1 gene for esophageal squamous cell carcinoma by gene gun technology.
    Tanaka Y; Fujii T; Yamana H; Kato S; Morimatsu M; Shirouzu K
    Int J Mol Med; 2004 Oct; 14(4):545-51. PubMed ID: 15375580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amplification of int-2 gene in primary esophageal carcinoma and fetal esophageal carcinoma induced by N-methyl-N-benzylnitrosamine (NMBzA)].
    Guo YJ
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):91-3. PubMed ID: 8223132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.
    Mori T; Miura K; Aoki T; Nishihira T; Mori S; Nakamura Y
    Cancer Res; 1994 Jul; 54(13):3396-7. PubMed ID: 8012957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene activation in esophageal cancer.
    Casson AG; Mukhopadhyay T; Cleary KR; Ro JY; Levin B; Roth JA
    J Thorac Cardiovasc Surg; 1991 Nov; 102(5):707-9. PubMed ID: 1943188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.